Alzheimer’s disease is a progressive memory disorder that affects nearly one in three seniors and is on the rise, currently affecting 43 million people worldwide.
Behind the memory impairments, there is a perfect storm of destruction in the brain, stemming in part from accumulations of a protein called tau. Normally a stabilizing structure inside of neurons, tau can accumulate in long tangles that disrupt the ability of neurons to communicate with one another.
University of New Mexico researchers have developed a vaccine that could prevent the formation of the tau tangles and potentially prevent the cognitive decline typically seen in Alzheimer’s patients.
In a paper published last week in NPJ Vaccines, the team reported it had engineered a vaccine using virus-like particles (VLPs, for short) that eliminated the tau tangles in mice that had been bred to develop symptoms like those affecting human Alzheimer’s patients.
“We’re excited by these findings, because they seem to suggest that we can use the body’s own immune system to make antibodies against these tangles, and that these antibodies actually bind and clear these tau tangles,” said Nicole Maphis, a PhD candidate in UNM’s Biomedical Sciences Graduate Program.
Maphis, working in the lab of Kiran Bhaskar, PhD, an associate professor in UNM’s Department of Molecular Genetics & Microbiology, found that when the vaccine was given to mice, they developed antibodies that cleared the tau protein from their brains – and the response lasted for months.
Then, she tested the animals in a battery of maze-like tests. Mice receiving the vaccination performed remarkably better than those that hadn’t. MRI scans showed that the vaccinated animals had less brain shrinkage, suggesting that the vaccine prevented neurons from dying.
Maphis also found significantly fewer tangles in both the cortex and the hippocampus – areas in the brain that are important for learning and memory, and which are destroyed in Alzheimer’s.
“These results confirm that targeting tau tangles using a vaccine intervention could rescue memory impairments and prevent neurons from dying,” Maphis said.
The vaccine was created with help from UNM scientists David Peabody and Bryce Chackerian. The pair helped pioneer the use of VLPs to create vaccines targeting dengue virus, hepatitis B, human papillomavirus and amyloid beta protein (which is also present in the brains of Alzheimer’s patients).
VLPs are derived from viruses that have their genomes removed, leaving only their outer protein shell. Lacking a genome, they’re unable to reproduce, but the body’s immune system still recognizes them as foreign invaders and manufactures antibodies to neutralize the proteins attached to their surface. In this case, a portion of tau protein on the surface of the VLP triggers an immune response, leading to the elimination of the tau tangles.
Going forward, Bhaskar hopes to obtain funding to commercialize this vaccine in order to create an injection that could potentially be tested in human patients. However, moving a drug from bench to bedside can cost millions of dollars and take decades.
By partnering with AgilVax, Inc., a company formed to commercialize the VLP technology, and STC.UNM (UNM’s technology commercialization arm), Bhaskar hopes to receive funding from a federal Small Business Innovation Research grant to help move the research project forward.
Learn more: Memory Preserver
The Latest on: Alzheimer’s vaccine
via Google News
The Latest on: Alzheimer’s vaccine
- Could flu vaccines lower your risk of Alzheimer’s? Research sheds new lighton August 10, 2020 at 2:01 am
The first study, conducted at the McGovern Medical School at the University of Texas Health Science Center in Houston, was done because previous research had shown a possible connection between ...
- Biogen's Alzheimer's Drug And Other News: The Good, Bad And Ugly Of Biopharmaon August 9, 2020 at 1:04 am
Biogen receives priority review for Alzheimer’s drug candidate. PTC Therapeutics receives FDA nod for Evrysdi.
- Another Reason to Get the Flu Shot, Study Finds It May Decrease Risk of Alzheimer’son August 4, 2020 at 4:17 pm
New research has found that the flu shot and pneumonia vaccine can reduce people’s risk of developing Alzheimer’s.
- New Research Finds Flu And Pneumonia Vaccines May Lower Alzheimer's Riskon August 2, 2020 at 5:36 am
With vaccines top of mind at the White House and across the globe during the coronavirus pandemic, two studies presented this week at the Alzheimer’s Association International Conference (AAIC) 2020, ...
- Vaccines for flu and pneumonia could reduce your chances of getting Alzheimer’son July 29, 2020 at 11:00 am
Two common vaccines may come with an unexpected benefit, preliminary research indicates. Two teams of medical researchers found that people who got the seasonal flu or pneumonia vaccine were less ...
- Flu, Pneumonia Vaccines May Lower Alzheimer's Riskon July 28, 2020 at 2:18 pm
New research finds that having a flu shot could lower Alzheimer’s risk and that the pneumonia vaccine might have protective qualities for dementia risk.
- Alzheimer's Tau Vaccine; Anosmia and COVID-19; Ketamine for MS Fatigueon July 28, 2020 at 11:41 am
An Alzheimer's vaccine candidate designed to generate a specific antibody response against pathologic phospho-tau (p-tau) proteins advanced to phase Ib/II clinical trials, AC Immune announced.
- Pneumonia vaccine may cut Alzheimer's risk by up to 40%on July 27, 2020 at 12:29 pm
A new study from Duke University found that receiving the pneumonia vaccine reduces the risk of developing Alzheimer's by 25% to 30% and up to 40% in those without genetic risk factors.
- Flu vaccine may reduce risk of Alzheimer's disease, new study showson July 27, 2020 at 10:03 am
People who received at least one flu vaccination were 17% less likely to get Alzheimer's disease over the course of a lifetime, according to researchers at UTHealth.
- Flu vaccine may reduce risk of Alzheimer’s disease, study showson July 27, 2020 at 9:41 am
Researchers found people who received at least one flu vaccination were 17% less likely to get Alzheimer’s disease over the course of a lifetime.
via Bing News